Monitor for additional equity grants or insider activity, especially given the activist context; while this filing is routine, a pattern of equity inducements could signal talent retention challenges or dilutive practices.
Price Chart
Executive Summary
Spyre Therapeutics granted stock options to purchase 70,200 shares to five non-executive employees as inducement awards under its 2018 Equity Inducement Plan. The options have a 10-year term, an exercise price of $48.90, and vest over four years, with one-fourth vesting on the first anniversary and monthly thereafter, subject to continued service.
Key Facts
- Spyre granted stock options for 70,200 shares to five non-executive employees.
- Options were granted under Nasdaq Listing Rule 5635(c)(4) as inducement awards.
- Exercise price is $48.90, equal to the closing price on April 1, 2026.
- Options have a 10-year term and vest 25% on first anniversary, then 1/48th monthly over next 36 months.
- Grants were material to employment acceptances.
Financial Impact
Minimal near-term financial impact; total potential dilution of 70,200 shares (~0.19% of $3.7B market cap at $48.90).
Risk Factors
- Potential for incremental shareholder dilution if future inducement grants scale significantly.
- Activist scrutiny may increase if governance or compensation practices are perceived as excessive.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3268133 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | Insider Cluster | $88.98 $90.80 | ▼ −2.05% | ▼ −3.25% | $93.19 (−4.73%) |
Aug 11, 2026 7w ago | Insider Cluster | $102.74 $107.82 | ▼ −4.94% | ▼ −5.35% | $93.19 (+9.30%) |
Aug 6, 2026 8w ago | Insider Cluster | $103.42 $101.85 | ▲ +1.52% | ▲ +2.73% | $93.19 (+9.89%) |
Jul 3, 2026 13w ago | Insider Cluster | $86.63 $98.75 | ▲ +13.99% | ▲ +13.06% | $93.19 (+7.57%) |
Jun 27, 2026 13w ago | Insider Cluster | $90.16 $88.74 | ▲ +1.57% | ▲ +2.96% | $93.19 (−3.36%) |
Jun 26, 2026 14w ago | S-3ASR | $90.16 $88.74 | ▼ −1.57% | ▼ −2.96% | $93.19 (+3.36%) |
Jun 24, 2026 14w ago | Insider Cluster | $86.24 $88.89 | ▼ −3.07% | ▼ −1.37% | $93.19 (−8.06%) |
Jun 15, 2026 15w ago | 8-K | $83.58 $100.32 | ▲ +20.03% | ▲ +21.41% | $93.19 (+11.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $80.79 $88.34 | ▲ +9.35% | ▲ +8.67% | $93.19 (+15.35%) |
Jun 11, 2026 16w ago | Institutional Cluster | $80.77 $87.49 | ▲ +8.32% | ▲ +7.89% | $93.19 (+15.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access